176 related articles for article (PubMed ID: 35533042)
1. Mohs Micrographic Surgery in Skin of Color.
Williams R; Ciocon D
J Drugs Dermatol; 2022 May; 21(5):536-541. PubMed ID: 35533042
[TBL] [Abstract][Full Text] [Related]
2. Suture Selection to Minimize Postoperative Postinflammatory Hyperpigmentation in Patients With Skin of Color During Mohs Micrographic Surgery.
Bravo CG; Negbenebor NA
Cutis; 2023 Nov; 112(5):227-228. PubMed ID: 38091440
[TBL] [Abstract][Full Text] [Related]
3. Postinflammatory Hyperpigmentation Following Mohs Micrographic Surgery: An Observational Study.
Hossain OB; Labiak A; Mieczkowska K; Srikantha R; Ciocon DH; Williams RF
J Drugs Dermatol; 2024 May; 23(5):316-321. PubMed ID: 38709696
[TBL] [Abstract][Full Text] [Related]
4. Characterizing cutaneous malignancies in patients with skin of color treated with Mohs micrographic surgery.
Juarez MC; Criscito MC; Pulavarty A; Stevenson ML; Carucci JA
J Am Acad Dermatol; 2023 Aug; 89(2):355-357. PubMed ID: 36965670
[No Abstract] [Full Text] [Related]
5. Consistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery.
Horeczko J; Hendi A
J Drugs Dermatol; 2022 May; 21(5):506-509. PubMed ID: 35533023
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery.
Cook JL; Perone JB
Arch Dermatol; 2003 Feb; 139(2):143-52. PubMed ID: 12588220
[TBL] [Abstract][Full Text] [Related]
7. Mohs Micrographic Surgery for Genital Skin Cancer: A Review of Cases and Reconstructive Techniques.
Zhu TH; Zhu TR; Routt E; Ciocon D
J Drugs Dermatol; 2021 Mar; 20(3):311-319. PubMed ID: 33683082
[TBL] [Abstract][Full Text] [Related]
8. Underutilization of Mohs Micrographic Surgery for Less Common Cutaneous Malignancies in the United States.
Ghareeb ER; Dulmage BO; Vargo JA; Balasubramani GK; Beriwal S
Dermatol Surg; 2016 May; 42(5):653-62. PubMed ID: 27054447
[TBL] [Abstract][Full Text] [Related]
9. Impact of the COVID Pandemic on Mohs Micrographic Surgery: A Nationwide Survey.
Seger E; Neill B; Hocker T; Ibrahimi O
J Drugs Dermatol; 2022 May; 21(5):545-547. PubMed ID: 35533028
[TBL] [Abstract][Full Text] [Related]
10. Understanding Mohs Micrographic Surgery: A Review and Practical Guide for the Nondermatologist.
Tolkachjov SN; Brodland DG; Coldiron BM; Fazio MJ; Hruza GJ; Roenigk RK; Rogers HW; Zitelli JA; Winchester DS; Harmon CB
Mayo Clin Proc; 2017 Aug; 92(8):1261-1271. PubMed ID: 28778259
[TBL] [Abstract][Full Text] [Related]
11. A Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery.
Otto TS; Ragi SD; John AM; Bhatti H
J Drugs Dermatol; 2024 May; 23(5):380. PubMed ID: 38709685
[TBL] [Abstract][Full Text] [Related]
12. MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgery.
Sharma AN; Peterman N; Juhasz M; Shive M
Arch Dermatol Res; 2023 Dec; 316(1):21. PubMed ID: 38060044
[TBL] [Abstract][Full Text] [Related]
13. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients.
Nelson RA; Arlette JP
Ann Plast Surg; 2008 Jun; 60(6):667-72. PubMed ID: 18520205
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Primary Defect Characteristics on Reconstruction Type and Adjunctive Intervention in Mohs Micrographic Surgery: A Retrospective Review.
Trujillo O; Obayemi A; Askin G; Navrazhina K; Cressey BD; Joshi R; Minkis K; Sclafani A
J Drugs Dermatol; 2020 Mar; 19(3):264-270. PubMed ID: 32550697
[TBL] [Abstract][Full Text] [Related]
15. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.
Alam M; Ibrahim O; Nodzenski M; Strasswimmer JM; Jiang SI; Cohen JL; Albano BJ; Batra P; Behshad R; Benedetto AV; Chan CS; Chilukuri S; Crocker C; Crystal HW; Dhir A; Faulconer VA; Goldberg LH; Goodman C; Greenbaum SS; Hale EK; Hanke CW; Hruza GJ; Jacobson L; Jones J; Kimyai-Asadi A; Kouba D; Lahti J; Macias K; Miller SJ; Monk E; Nguyen TH; Oganesyan G; Pennie M; Pontius K; Posten W; Reichel JL; Rohrer TE; Rooney JA; Tran HT; Poon E; Bolotin D; Dubina M; Pace N; Kim N; Disphanurat W; Kathawalla U; Kakar R; West DP; Veledar E; Yoo S
JAMA Dermatol; 2013 Dec; 149(12):1378-85. PubMed ID: 24080866
[TBL] [Abstract][Full Text] [Related]
16. Diversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship.
Hoffman L; Benesh G; Soliman Y; Ciocon D; Williams R
J Drugs Dermatol; 2023 May; 22(5):471-474. PubMed ID: 37133480
[TBL] [Abstract][Full Text] [Related]
17. Mohs surgeon workforce survey: a spectrum of clinical, academic, and leadership activities.
Scott JF; Lam C; Ahn JW; Yu SH
Arch Dermatol Res; 2023 Dec; 316(1):30. PubMed ID: 38060032
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery as treatment option for non-basal cell or squamous cell carcinomas in the United States.
Puyana C; Zimmerman L; Tsoukas MM
J Dermatolog Treat; 2020 Sep; 31(6):567-570. PubMed ID: 31474170
[No Abstract] [Full Text] [Related]
19. Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons From 2012-2017.
Patel P; Guzman AK; Tinklepaugh A; Ciocon D
J Drugs Dermatol; 2021 Aug; 20(8):905-906. PubMed ID: 34397191
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery.
Bowen GM; White GL; Gerwels JW
Am Fam Physician; 2005 Sep; 72(5):845-8. PubMed ID: 16156344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
